Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA

Circulating tumor DNA (ctDNA) is an emerging biomarker for many cancers, but the limited sensitivity of current detection methods reduces its utility for diagnosing minimal residual disease. Here we describe phased variant enrichment and detection sequencing (PhasED-Seq), a method that uses multiple...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurtz, David M., Soo, Joanne, Keh, Lyron Co Ting, Alig, Stefan, Chabon, Jacob J., Sworder, Brian J., Schultz, Andre, Jin, Michael C., Scherer, Florian, Garofalo, Andrea, Macaulay, Charles W., Hamilton, Emily G., Chen, Binbin, Olsen, Mari, Schroers-Martin, Joseph G., Craig, Alexander F.M., Moding, Everett J., Esfahani, Mohammad S., Liu, Chih Long, Dührsen, Ulrich, Hüttmann, Andreas, Casasnovas, René-Olivier, Westin, Jason R., Roschewski, Mark, Wilson, Wyndham H., Gaidano, Gianluca, Rossi, Davide, Diehn, Maximilian, Alizadeh, Ash A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678141/
https://www.ncbi.nlm.nih.gov/pubmed/34294911
http://dx.doi.org/10.1038/s41587-021-00981-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678141/
https://www.ncbi.nlm.nih.gov/pubmed/34294911
http://dx.doi.org/10.1038/s41587-021-00981-w

Ejemplares similares